Spatial and temporal control of gene therapy using ionizing radiation

Activation of transcription of the Egr-1 gene by X-rays is regulated by the promoter region of this gene. We linked the radiation-inducible promoter region of the Egr-1 gene to the gene encoding the radiosensitizing and tumoricidal cytokine, tumour necrosis factor- (TNF-) and used a replication-deficient adenovirus to deliver the Egr-TNF construct to human tumours growing in nude mice. Combined treatment with Ad5.Egr-TNF and 5,000 cGy (rad) resulted in increased intratumoral TNF- production and increased tumour control compared with treatment with Ad5.Egr-TNF alone or with radiation alone. The increase in tumour control was achieved without an increase in normal tissue damage when compared to tissue injury from radiation alone. Control of gene transcription by iohizing radiation in vivo represents a novel method of spatial and temporal regulation of gene-based medical treatments.

1. Culver, K. & Blaese, R.M. Gene therapy for cancer. Trends Genet 10, 174−178 (1994).
2. Anderson, W. Gene therapy for cancer. Hum. Gene Ther. 5, 1−2 (1994).
3. Takaku, F. Clinical application of cytokines for cancer treatment. Oncology 51, 123−128 (1994).
4. Patel, P., Flemming, C., Russell, S., Eccles, S. & Collins, M. Cytokine gene transfer as a therapeutic strategy. J. Immunother. 14, 310−313 (1993).
5. Kasahara, N., Dozy, A. & Kan, Y. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373−1376 (1994).
6. Manome, Y., Abe, M., Hagen, M., Fine, H. & Kufe, D. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene. Cancer Res. 54, 5408−5413 (1994).
7. Old, L.J. Tumour necrosis factor. Science 230, 630−636 (1985).
8. Larrick, J.W. & Wright, S.C. Cytotoxic mechanism of tumour necrosis factor-. FASEB J. 4, 3215−3223 (1990).
9. Wright, S. & Larrick, J. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J. cell. Biochem. 48, 344−355 (1992).
10. Laster, S., Wood, J. & Gooding, L. TNF can induce both apoptic and necrotic forms of cell lysis. J. Immun. 141, 2629−2634 (1988).
11. Sersa, G., Willingham, V. & Milas, L. Anti-tumour effects of tumour necrosis factor alone or combined with radiotherapy. Int. J. Cancer 42, 129−134 (1988).
12. Hallahan, D.E., Spriggs, D.R., Beckett, M.A., Kufe, D.W. & Weichselbaum, R.R. Increased tumour necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc. natn. Acad. Sci. U.S.A. 86, 10104−10107 (1989).
13. Hallahan, D.E., Beckett, M.A., Kufe, D. & Weichselbaum, R.R. The interaction between recombinant human tumour necrosis factor and radiation in 13 human tumour cell lines. Int. J. Rad. One. biol. Phys. 19, 69−74 (1990).
14. Weichselbaum, R. et al. Radiation targeting of gene therapy preferentially radiosensitizes tumour cells. Cancer Res. 54, 4266−4269 (1994).
15. Wong, G., McHugh, T., Weber, R. & Goeddel, D. Tumour necrosis factor selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc. natn. Acad. Sci. U.S.A. 88, 4372−4376 (1991).
16. Gridley, D., Hammond, S. & Liwnicz, B. Tumour necrosis factor-alpha augments radiation effects against human colon tumour xenografts. Anticancer Res. 14, 1107−1112 (1994).
17. Huang, P. et al. The effect of combining rhTNF with radiation on tumour control of human glioblastoma multiforme xenograft in nude mice. Int. J. Radiat. Oncol, biol. Phys. (in the press).
18. Hallahan, D., Weichselbaum, R., Kufe, D. & Vokes, E. Phase I trial of tumour necrosis factor combined with radiotherapy. Cancer J. (in the press).
19. Herrlich, P., Ponta, H. & Rahmsdorf, H. DNA damaged-induced gene expression: signal transduction and relation to growth factor signaling. Rev. Physiol. Biochem. Pharmacol. 119, 187−223 (1992).
20. Weichselbaum, R.R., Hallahan, D.E. & Chen, G.T.Y. Biological and Physical Basis of Radiation Oncology. in Cancer Medicine (eds Holland, J. F. et al) 539−565 (Lea and Febiger, Malvern, Pennsylvania, 1993).
21. Holbrook, N. & Fornace, A. Response to adversity: molecular control of gene activation following genotoxic stress. New Biol. 3, 825−833 (1991).
22. Boothman, D., Bouvard, I. & Hughes, E. Identification and characterization of X-ray-induced proteins in human cells. Cancer Res. 49, 2871−2878 (1989).
23. Hallahan, D. et al. Radiation signalling mediated by Jun activation following dissociation from the Jun inhibitor. J. biol Chem. 268, 4903−4907 (1993).
24. Datta, R. et al. Ionizing radiation activates transcription of the Egr-1 gene via CArG elements. Proc. natn. Acad. Sci. U.S.A. 89, 10149−10153 (1992).
25. Brach, M., Sherman, M., Gunji, H., Weichselbaum, R. & Kufe, D. Ionizing radiation stimulates NF-B binding activity in human myeloid leukemia cells. J. clin. Invest. 88, 691−695 (1991).
26. Hallahan, D.E. et al Protein kinase-C mediates x-ray inducibility of nuclear signal transducers, egr-1 and c-jun. Proc. natn. Acad. Sci. U.S.A. 88, 2152−2160 (1991).
27. McGrory, Bautista & Graham. A simple technique for the rescue of early region I mutations into adenovirus typr 5. Virology 163, 614−617 (1988).
28. Jones, N. & Shenk, T. Isolation of Ad5 mutants defective for transformation. Cell 17, 683−689 (1979).
29. Weichselbaum, R.R., Dahlberg, W. & Little, J.B. Inherently radioresistant cells exist in some human tumours. Proc. natn. Acad. Sci. U.S.A. 82, 4732−4735 (1985).
30. Kasid, U. et al. Effect of anti-sense c-raf-1 on tumourgenicity and radiation sen-stivity of a human squamous cell carcinoma. Science 243, 1354−1356 (1989).
31. Gorcyca, W., Gong, J. & Darzynkiewicz, Z. Detection of DNA strandbreaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assay. Cancer Res. 53, 1945−1951 (1993).
32. Meyn, R.E. et al. Biochemical modulation of radiation-induced apoptosis in murine lympohoma cells. Radiat. Res. 136, 327−334 (1993).
33. Amin, R., Wilmott, R., Schwartz, Y., Trapnell, B.andStark, J. Replication-deficient adenovirus induces expression of interlukin-8 by airway epithelial cells in vitro. Hum. Gene Ther. 6, 145−153 (1995).
34. Kruskal, W.H. & Wallis, W.A. Use of ranks in one-criterion variance analysis. J. Am. Star. Assoc. 47, 583−621 (1952).

	Top

	Top